NIH-funded research R01 grant

A new ultrasound imaging system for early detection of breast cancer

Official title: B7-H3 Targeted Ultrasound Molecular Imaging System for Early Breast Cancer and Metastatic Detection

Funded at Stanford University · NIH-11093921 · Data updated 2026-11-12

This study is testing a new ultrasound method that uses special bubbles to help find breast cancer earlier and more accurately, especially for women with dense breast tissue, making it easier for doctors to diagnose and treat.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$579,412
NIH project number5R01EB031799-03
Project IDNIH-11093921 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women with dense breast tissue who are at risk for breast cancer.

Less likely to help

Patients with non-dense breast tissue or those who have already been diagnosed with advanced breast cancer may not benefit from this research.

What this research studies

This research focuses on developing an advanced ultrasound molecular imaging system that uses targeted contrast microbubbles to detect breast cancer at an early stage. By binding to specific proteins found in breast tumors, this innovative technique aims to improve the accuracy of breast cancer diagnosis, especially in women with dense breast tissue. The system is designed to integrate seamlessly with existing ultrasound technology, making it accessible for use in breast imaging clinics. The goal is to enhance the noninvasive characterization of breast lesions and ultimately improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate detection of breast cancer, significantly improving survival rates.

How similar studies have gone: Previous research has shown promise in using targeted ultrasound imaging techniques for cancer detection, indicating that this approach could be effective.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Dahl, Jeremy — Stanford University
  • Study coordinator: Dahl, Jeremy

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.